
Subcutaneous Immunoglobulin (SCIG) Global Market Report 2025
Description
Subcutaneous Immunoglobulin (SCIG) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on subcutaneous immunoglobulin (scig) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for subcutaneous immunoglobulin (scig) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous immunoglobulin (scig) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product Type: Immunoglobulin A (IgA); Immunoglobulin G (IgG); Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders; Autoimmune Diseases; Neurological Disorders; Other Applications
3) By End-Use: Clinics; Hospitals; Homecare; Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1; IgA2
2) By Immunoglobulin G (IgG): IgG1; IgG2; IgG3; IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM; Hexameric IgM
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Prothena Corporation plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on subcutaneous immunoglobulin (scig) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for subcutaneous immunoglobulin (scig) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous immunoglobulin (scig) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product Type: Immunoglobulin A (IgA); Immunoglobulin G (IgG); Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders; Autoimmune Diseases; Neurological Disorders; Other Applications
3) By End-Use: Clinics; Hospitals; Homecare; Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1; IgA2
2) By Immunoglobulin G (IgG): IgG1; IgG2; IgG3; IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM; Hexameric IgM
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Prothena Corporation plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Subcutaneous Immunoglobulin (SCIG) Market Characteristics
- 3. Subcutaneous Immunoglobulin (SCIG) Market Trends And Strategies
- 4. Subcutaneous Immunoglobulin (SCIG) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Subcutaneous Immunoglobulin (SCIG) Growth Analysis And Strategic Analysis Framework
- 5.1. Global Subcutaneous Immunoglobulin (SCIG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Subcutaneous Immunoglobulin (SCIG) Market Growth Rate Analysis
- 5.4. Global Subcutaneous Immunoglobulin (SCIG) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Subcutaneous Immunoglobulin (SCIG) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Subcutaneous Immunoglobulin (SCIG) Total Addressable Market (TAM)
- 6. Subcutaneous Immunoglobulin (SCIG) Market Segmentation
- 6.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immunoglobulin A (IgA)
- Immunoglobulin G (IgG)
- Immunoglobulin M (IgM)
- 6.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Immunodeficiency Disorders
- Autoimmune Diseases
- Neurological Disorders
- Other Applications
- 6.3. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Clinics
- Hospitals
- Homecare
- Other End-Uses
- 6.4. Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin A (IgA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- IgA1
- IgA2
- 6.5. Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin G (IgG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- IgG1
- IgG2
- IgG3
- IgG4
- 6.6. Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin M (IgM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pentameric IgM
- Hexameric IgM
- 7. Subcutaneous Immunoglobulin (SCIG) Market Regional And Country Analysis
- 7.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market
- 8.1. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Subcutaneous Immunoglobulin (SCIG) Market
- 9.1. China Subcutaneous Immunoglobulin (SCIG) Market Overview
- 9.2. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Subcutaneous Immunoglobulin (SCIG) Market
- 10.1. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Subcutaneous Immunoglobulin (SCIG) Market
- 11.1. Japan Subcutaneous Immunoglobulin (SCIG) Market Overview
- 11.2. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Subcutaneous Immunoglobulin (SCIG) Market
- 12.1. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Subcutaneous Immunoglobulin (SCIG) Market
- 13.1. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Subcutaneous Immunoglobulin (SCIG) Market
- 14.1. South Korea Subcutaneous Immunoglobulin (SCIG) Market Overview
- 14.2. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Subcutaneous Immunoglobulin (SCIG) Market
- 15.1. Western Europe Subcutaneous Immunoglobulin (SCIG) Market Overview
- 15.2. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Subcutaneous Immunoglobulin (SCIG) Market
- 16.1. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Subcutaneous Immunoglobulin (SCIG) Market
- 17.1. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Subcutaneous Immunoglobulin (SCIG) Market
- 18.1. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Subcutaneous Immunoglobulin (SCIG) Market
- 19.1. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Subcutaneous Immunoglobulin (SCIG) Market
- 20.1. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market
- 21.1. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market Overview
- 21.2. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Subcutaneous Immunoglobulin (SCIG) Market
- 22.1. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Subcutaneous Immunoglobulin (SCIG) Market
- 23.1. North America Subcutaneous Immunoglobulin (SCIG) Market Overview
- 23.2. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Subcutaneous Immunoglobulin (SCIG) Market
- 24.1. USA Subcutaneous Immunoglobulin (SCIG) Market Overview
- 24.2. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Subcutaneous Immunoglobulin (SCIG) Market
- 25.1. Canada Subcutaneous Immunoglobulin (SCIG) Market Overview
- 25.2. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Subcutaneous Immunoglobulin (SCIG) Market
- 26.1. South America Subcutaneous Immunoglobulin (SCIG) Market Overview
- 26.2. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Subcutaneous Immunoglobulin (SCIG) Market
- 27.1. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Subcutaneous Immunoglobulin (SCIG) Market
- 28.1. Middle East Subcutaneous Immunoglobulin (SCIG) Market Overview
- 28.2. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Subcutaneous Immunoglobulin (SCIG) Market
- 29.1. Africa Subcutaneous Immunoglobulin (SCIG) Market Overview
- 29.2. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape And Company Profiles
- 30.1. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape
- 30.2. Subcutaneous Immunoglobulin (SCIG) Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Prothena Corporation plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 31. Subcutaneous Immunoglobulin (SCIG) Market Other Major And Innovative Companies
- 31.1. Amgen Inc.
- 31.2. Baxter International Inc.
- 31.3. CSL Behring
- 31.4. Lonza Group
- 31.5. Grifols S.A.
- 31.6. Octapharma AG
- 31.7. Dr. Reddy's Laboratories
- 31.8. Intas Pharmaceutical Ltd.
- 31.9. Emergent BioSolutions Inc.
- 31.10. Kedrion Biopharma
- 31.11. LFB Group
- 31.12. Biotest AG
- 31.13. Argenx SE
- 31.14. Bio Products Laboratory Ltd.
- 31.15. ADMA Biologics Inc.
- 32. Global Subcutaneous Immunoglobulin (SCIG) Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Subcutaneous Immunoglobulin (SCIG) Market
- 34. Recent Developments In The Subcutaneous Immunoglobulin (SCIG) Market
- 35. Subcutaneous Immunoglobulin (SCIG) Market High Potential Countries, Segments and Strategies
- 35.1 Subcutaneous Immunoglobulin (SCIG) Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Subcutaneous Immunoglobulin (SCIG) Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Subcutaneous Immunoglobulin (SCIG) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.